Ovation Science Inc. OVATF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -50.83% | -7.38% | 26.09% | -7.55% | -61.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.83% | -7.38% | 26.09% | -7.55% | -61.17% |
| Cost of Revenue | -- | -- | 508.70% | 195.00% | -100.00% |
| Gross Profit | -50.83% | -5.04% | -94.57% | -54.65% | -60.13% |
| SG&A Expenses | 25.20% | -5.07% | 149.27% | 9.21% | -17.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.20% | -5.40% | 157.68% | 12.50% | -19.68% |
| Operating Income | -35.43% | 5.07% | -183.03% | -14.96% | 6.30% |
| Income Before Tax | -30.78% | 8.26% | -817.55% | 25.42% | -74.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.78% | 8.26% | -817.55% | 25.42% | -74.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.78% | 8.26% | -817.55% | 25.42% | -74.19% |
| EBIT | -35.43% | 5.07% | -183.03% | -14.96% | 6.30% |
| EBITDA | -- | -- | -184.25% | -15.04% | 6.13% |
| EPS Basic | -17.86% | 16.67% | -840.00% | 24.32% | -47.37% |
| Normalized Basic EPS | -23.53% | 13.33% | -866.67% | 26.09% | -41.67% |
| EPS Diluted | -17.86% | 16.67% | -840.00% | 24.32% | -47.37% |
| Normalized Diluted EPS | -23.53% | 13.33% | -866.67% | 26.09% | -41.67% |
| Average Basic Shares Outstanding | 9.89% | 9.89% | 4.07% | 0.00% | 19.09% |
| Average Diluted Shares Outstanding | 9.89% | 9.89% | 4.07% | 0.00% | 19.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |